Clinical Analysis of Treatment and Prognosis of Patients with Pain Caused by Malignant Bone Metastasis
- VernacularTitle:恶性肿瘤骨转移疼痛患者治疗及预后的临床分析
- Author:
Rui MA
;
Xiujuan QU
;
Yunpeng LIU
;
Zhi LI
;
Jing LIU
;
Yuee TENG
- Publication Type:Journal Article
- Keywords:
bone metastasis;
pain;
clinical analysis;
survival time;
medication rationality
- From:Journal of China Medical University
2015;(5):443-447
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the clinical features,therapeutic effect and prognosis in patients with bone pain induced by malignant bone me?tastasis as well as the rationality of analgesic application,so as to improve the level of diagnosis and treatment for metastatic bone pain. Methods Totally 123 patients with pain due to malignant bone metastasis received antitumor therapy and analgesic therapy based on standardized three?step guidelines. Their clinical characteristics were retrospectively analyzed. Results The total pain relief rate was 85.4%and the pain was significantly relieved(P<0.05). The DUI value of each narcotic agent was close to 1 and the application of narcotic agents tended to be rational. The Kaplan?Meier survival analysis showed that patients with moderate pain had longer survival time than those with severe pain(P=0.015). The survival rate of patients with significant pain relief after treatment was higher than those unrelieved(P=0.021). The survival rate of patients without visceral me?tastasis was higher than those with visceral metastasis(P=0.000). The COX multivariate analysis indicated that the pain intensity and visceral me?tastasis were independent risk factors influencing patient prognosis. Conclusion Standard treatment can improve symptoms in most patients with bone metastasis and prolong survival time. Opioids have satisfactory analgesic effect for moderate to severe pain and the adverse reactions can be tol?erated.
